Literature DB >> 1972763

Multiple sclerosis and HLA class II susceptibility and resistance genes.

D G Haegert1, M Michaud, C Schwab, G S Francis.   

Abstract

Probes to the HLA class II genes DR beta, DQ beta, and DQ alpha were used to study DNA from unrelated Caucasian multiple sclerosis (MS) patients by sequential restriction fragment length polymorphism (RFLP) analysis in Taq 1 restriction enzyme digests. Comparison of 104 patients and 108 controls, who were not matched for DR type, has identified for the first time a linked series of allele-specific RFLPs or allogenotypes which form an extended haplotype that is preferentially associated with MS. These allogenotypes include DRw15 or DR2(15); DQ beta lb, which corresponds at the DNA level to the DQwl(DQw6) serotype; a DQA1 allogenotype termed DQ alpha lb; and a 2.2 kb DX (DQA2) allogenotype termed DX alpha U (DQA2U). The role of HLA class II genes in susceptibility to MS was found to be complex. First, 23 of 104 MS patients showed DR-DQ linkages which were not observed in our control population. We suggest these anomalous associations may be important in the pathogenesis of MS. Second, homozygosity of a 2.0 kb DX (DQA2) gene, termed DX alpha L (DQA2L), showed a strong negative association with MS. DX alpha L (DQA2L) is in strong linkage disequilibrium with DR1, 5(w11) 7, and a subset of DR4, all of which also showed a negative association with MS. Since DX alpha L (DQA2L) does not code for any known product, DR1, 5(11), 4, and 7 become candidates for disease resistance genes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972763     DOI: 10.1002/jnr.490260108

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  5 in total

Review 1.  Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers.

Authors:  Vera Pravica; Dusan Popadic; Emina Savic; Milos Markovic; Jelena Drulovic; Marija Mostarica-Stojkovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  HLA class II susceptibility and resistance genes in patients with multiple sclerosis from northern Spain, by DNA-RFLP genotyping.

Authors:  D F Uría; V Gutierrez; B B Menes; J M Arribas; C Lopez-Larrea
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

3.  HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).

Authors:  Oscar Fernández; Alfredo R-Antigüedad; María Jesús Pinto-Medel; Mari Mar Mendibe; Nestor Acosta; Begoña Oliver; Miguel Guerrero; Marcos Papais-Alvarenga; Victoria Fernández-Sánchez; Laura Leyva
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

4.  Assessment of IL-7RA T244I Polymorphism as a Risk Factor of Multiple Sclerosis in Turkish Population.

Authors:  Miraç Aysen Ünsal; Nüket Yıldız Manukyan; Nihal IŞik; Güher Saruhan Dİreskenelİ
Journal:  Noro Psikiyatr Ars       Date:  2019-08-26       Impact factor: 1.339

5.  T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis.

Authors:  L L Perry; E Barzaga-Gilbert; J L Trotter
Journal:  J Neuroimmunol       Date:  1991-07       Impact factor: 3.478

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.